Exantas Capital - XAN Stock Forecast, Price & News

Exantas Capital Corp. (NYSE:XAN) announced its quarterly earnings results on Wednesday, November, 4th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.27. Exantas Capital had a negative net margin of 347.93% and a positive trailing twelve-month return on equity of 8.10%.
Read the conference call transcript.

Exantas Capital (NYSE:XAN) pays an annual dividend of $3.30 per share and currently has a dividend yield of 21.15%. XAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 330.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, XAN will have a dividend payout ratio of 2,538.46% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for XAN.

Exantas Capital's stock reverse split before market open on Tuesday, February 16th 2021. The 1-3 reverse split was announced on Thursday, February 4th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 15th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

4 employees have rated Exantas Capital Chief Executive Officer Bill Alexander on Glassdoor.com. Bill Alexander has an approval rating of 82% among the company's employees. 85.0% of employees surveyed would recommend working at Exantas Capital to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exantas Capital investors own include EnLink Midstream (ENLC), Golar LNG Partners (GMLP), New Residential Investment (NRZ), New York Mortgage Trust (NYMT), Two Harbors Investment (TWO), Washington Prime Group (WPG), ADMA Biologics (ADMA), Hallador Energy (HNRG), Redwood Trust (RWT) and Zosano Pharma (ZSAN).

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

One share of XAN stock can currently be purchased for approximately $8.70.

Exantas Capital (NYSE:XAN) has a market capitalization of $279.21 million and generates $61.15 million in revenue each year. The company earns $35.97 million in net income (profit) each year or $1.00 on an earnings per share basis.

Exantas Capital's mailing address is 865 MERRICK AVENUE, NEW YORK NY, 11590. The official website for the company is www.exantas.com. The company can be reached via phone at 516-535-0015 or via email at slandgraber@exantas.com.